Cargando…
Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer
Gastric cancer (GC) is fifth most frequently diagnosed cancer and second leading cause of cancer in China. More than 80% of GC are diagnosed at an advanced stage due to low uptake rate of invasive screening method. The performance of methylated SFRP2 test was evaluated in 236 plasma samples, includi...
Autores principales: | Miao, Jin, Liu, Yi, Zhao, Guodong, Liu, Xiaoyu, Ma, Yong, Li, Hui, Li, Shiming, Zhu, Yun, Xiong, Shangmin, Zheng, Minxue, Fei, Sujuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218304/ https://www.ncbi.nlm.nih.gov/pubmed/32379490 http://dx.doi.org/10.1177/1073274820922559 |
Ejemplares similares
-
Methylated SFRP2 and SDC2 in stool specimens for Colorectal Cancer early detection: A cost-effective strategy for Chinese population
por: Zhao, Guodong, et al.
Publicado: (2021) -
Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
por: Liu, Yi, et al.
Publicado: (2020) -
Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020) -
Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection
por: Chen, Zhiliang, et al.
Publicado: (2021) -
Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening
por: Zhao, Guodong, et al.
Publicado: (2019)